Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine versus digoxin for chronic heart rate control in permanent atrial fibrillation
2018-001936-23Phase 3Completed
- Sponsor
- Dr. Adolfo Fontenla Cerezuela
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Atrial fibrillation (AFib) comparing Ivabradine arm with Digoxin arm (2 arms). Primary endpoints: Reduction in mean daytime heart rate and Safety events. Started Aug 2018; status: completed.
02
Drugs
ivabradinedigoxin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2018-001936-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001936-23.